Company Filing History:
Years Active: 1998-2000
Title: Chris Y Ho: Innovator in Pharmaceutical Formulations
Introduction
Chris Y Ho is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of sustained-release dosage forms. With a total of 2 patents to his name, his work focuses on improving the efficacy and reliability of medication delivery.
Latest Patents
Chris Y Ho's latest patents include innovative formulations for immediate release and sustained release compressed tablets. One of his inventions involves an orally administrable sustained-release dosage form that includes particles of an active pharmaceutical ingredient coated with a polymeric material. This material is water-insoluble, yet water-permeable and water-swellable, allowing for controlled release that is independent of variable physiological factors such as pH. The active pharmaceutical ingredient in this formulation is acetaminophen, which is combined with uncoated acetaminophen particles to create a combination immediate-release/sustained-release dosage form. Another aspect of his invention involves the use of a methacrylate ester copolymer for coating the active ingredient, ensuring that the release rate remains substantially independent of physiological factors. The final dosage forms can be presented as compressed tablets, capsules, or pouches.
Career Highlights
Chris Y Ho is currently employed at L. Perrigo Company, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the field of drug delivery systems, particularly in creating formulations that enhance patient compliance and therapeutic outcomes.
Collaborations
Chris has collaborated with Shirish A Shah, contributing to the development of advanced pharmaceutical formulations. Their partnership has led to significant advancements in the field, showcasing the importance of teamwork in innovation.
Conclusion
Chris Y Ho is a prominent inventor whose work in pharmaceutical formulations has the potential to greatly impact medication delivery. His innovative approaches to sustained-release dosage forms demonstrate his commitment to improving healthcare outcomes.